-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Celldex Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2010 to 2023.
- Celldex Therapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $48.8M, a 45.8% increase year-over-year.
- Celldex Therapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $184M, a 47.9% increase year-over-year.
- Celldex Therapeutics, Inc. annual Costs and Expenses for 2023 was $161M, a 37.3% increase from 2022.
- Celldex Therapeutics, Inc. annual Costs and Expenses for 2022 was $118M, a 54.9% increase from 2021.
- Celldex Therapeutics, Inc. annual Costs and Expenses for 2021 was $75.9M, a 7.24% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)